Ignite Creation Date:
2024-05-06 @ 4:18 PM
Last Modification Date:
2024-10-26 @ 2:07 PM
Study NCT ID:
NCT04943497
Status:
RECRUITING
Last Update Posted:
2024-02-22
First Post:
2021-06-21
Brief Title:
A Prospective Observational Study to Describe Clinical Outcomes Treatment Patterns Patients Characteristics Among Patients With HRHER2- Advanced BC Initiating Treatment With Risarg Piqray Endocrine Therapy or Chemotherapy in Routine Clinical Practice in Russia
Sponsor:
Organization:
Novartis
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
3290
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 76669 |
Who Masked List: